Taku Kobayashi

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 38

Top Venues

Nature reviews. Gastroenterology & hepatology

Journal of gastroenterology and hepatology

Alimentary pharmacology & therapeutics

Journal of Crohn's & colitis

Nagoya University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Nagoya University

Japan

PHD

Publications

Taku Kobayashi, Toshifumi Hibi
Author Correction: Improving IBD outcomes in the era of many treatment options. Nature reviews. Gastroenterology & hepatology (2023)
Taku Kobayashi, Toshifumi Hibi
Improving IBD outcomes in the era of many treatment options. Nature reviews. Gastroenterology & hepatology 20 (2) (2023)
Taku Kobayashi, Toshifumi Hibi
Improving IBD outcomes in the era of many treatment options. Nature reviews. Gastroenterology & hepatology 20 (2) (2023)
Joel Shor, Yusuke Miyatani, Etsuko Arita, Pohung Chen, Yusuke Ito, Hiroki Kayama, Jacob Reiter, Kaho Kobayashi, Taku Kobayashi
Reducing Health Anxiety in Patients With Inflammatory Bowel Disease Using Video Testimonials: Pilot Assessment of a Video Intervention. JMIR formative research 7 (2023)
Kaoru Takabayashi, Taku Kobayashi, Katsutoshi Matsuoka, Barrett G Levesque, Takuji Kawamura, Kiyohito Tanaka, Takeaki Kadota, Ryoma Bise, Seiichi Uchida, Takanori Kanai, Haruhiko Ogata
Artificial Intelligence Quantifying Endoscopic Severity of Ulcerative Colitis in Gradation Scale. Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society (2023)
Taku Kobayashi, Toshifumi Hibi
Improving IBD outcomes in the era of many treatment options. Nature reviews. Gastroenterology & hepatology (2023)
Matthieu Allez, Bruce E Sands, Brian G Feagan, Geert D'Haens, Gert De Hertogh, Charles W Randall, Bin Zou, Jewel Johanns, Christopher O'Brien, Mark Curran, Rory Rebuck, Mei-Lun Wang, Nina Sabins, Thomas Baker, Taku Kobayashi
A Phase 2b, Randomized, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients With Moderately to Severely Active Crohn's Disease. Journal of Crohn's & colitis (2023)
Taku Kobayashi, Toshifumi Hibi
Author Correction: Improving IBD outcomes in the era of many treatment options. Nature reviews. Gastroenterology & hepatology (2023)
Satoshi Yamada, Yusuke Honzawa, Shuji Yamamoto, Minoru Matsuura, Hiroki Kitamoto, Makoto Okabe, Nobuyuki Kakiuchi, Takahiko Toyonaga, Taku Kobayashi, Toshifumi Hibi, Hiroshi Seno, Hiroshi Nakase
Single Nucleotide Polymorphisms of the MEFV Gene E148Q Are Highly Associated With Disease Phenotype in Crohn's Disease. Inflammatory bowel diseases (2023)
Ferdinando D'Amico, Fernando Magro, Benedicte Caron, Axel U Dignass, Vipul Jairath, Ailsa Hart, Paulo Gustavo Kotze, Kristine Paridaens, Sameer Al Awadhi, Taku Kobayashi, Britta Siegmund, Laurent Peyrin-Biroulet, Silvio Danese
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis. Journal of clinical medicine 12 (3) (2023)
Taku Kobayashi, Toshifumi Hibi
Improving IBD outcomes in the era of many treatment options. Nature reviews. Gastroenterology & hepatology 20 (2) (2023)
Kunio Asonuma, Keiji Ozeki, Hajime Yamazaki, Shinji Okabayashi, Soh Okano, Ryo Ozaki, Nobuaki Nishimata, Hiroki Kiyohara, Naoki Ichinari, Taku Kobayashi, Masahiro Yamada, Mao Matsubayashi, Yoko Yokoyama, Shoko Arimitsu, Junji Umeno, Yoshinori Munetomo, Katsuyoshi Ando, Shinichiro Shinzaki, null null
Immunomodulators after the discontinuation of anti-tumor necrosis factor-alpha antibody treatment and relapse in ulcerative colitis: A multicenter cohort study. Journal of gastroenterology and hepatology (2023)
Taku Kobayashi, Toshifumi Hibi
Improving IBD outcomes in the era of many treatment options. Nature reviews. Gastroenterology & hepatology (2023)
Taku Kobayashi, Toshifumi Hibi
Improving IBD outcomes in the era of many treatment options. Nature reviews. Gastroenterology & hepatology (2023)
Joel Shor, Yusuke Miyatani, Etsuko Arita, Pohung Chen, Yusuke Ito, Hiroki Kayama, Jacob Reiter, Kaho Kobayashi, Taku Kobayashi
Reducing Health Anxiety in Patients With Inflammatory Bowel Disease Using Video Testimonials: Pilot Assessment of a Video Intervention. JMIR formative research 7 (2023)
Takeshi Ueda, Fumikazu Koyama, Akira Sugita, Hiroki Ikeuchi, Kitaro Futami, Kouhei Fukushima, Riichiro Nezu, Hideki Iijima, Tsunekazu Mizushima, Michio Itabashi, Kazuhiro Watanabe, Keisuke Hata, Takahide Shinagawa, Katsuyoshi Matsuoka, Kento Takenaka, Makoto Sasaki, Manabu Nagayama, Hironori Yamamoto, Masaru Shinozaki, Mikihiro Fujiya, Jun Kato, Yoshitaka Ueno, Shinji Tanaka, Yoshiki Okita, Yoshinari Hashimoto, Taku Kobayashi, Kazutaka Koganei, Motoi Uchino, Hisao Fujii, Yasuo Suzuki, Tadakazu Hisamatsu
Endoscopic lesions of postoperative anastomotic area in patients with Crohn's disease in the biologic era: A Japanese multi-center nationwide cohort study. Journal of Crohn's & colitis (2023)
Kenji Watanabe, Masanori Nojima, Hiroshi Nakase, Toshiyuki Sato, Minoru Matsuura, Nobuo Aoyama, Taku Kobayashi, Hirotake Sakuraba, Masakazu Nishishita, Kaoru Yokoyama, Motohiro Esaki, Fumihito Hirai, Masakazu Nagahori, Sohachi Nanjo, Teppei Omori, Satoshi Tanida, Yoshihiro Yokoyama, Kei Moriya, Atsuo Maemoto, Osamu Handa, Naoki Ohmiya, Kiichiro Tsuchiya, Shinichiro Shinzaki, Shingo Kato, Masashi Namikawa, Hiroki Tanaka, Noritaka Takatsu, Atsushi Nishida, Junji Umeno, Masanao Nakamura, Yoshiyuki Mishima, Mikihiro Fujiya, Kenji Tsuchida, Sakiko Hiraoka, Makoto Okabe, Takahiko Toyonaga, Katsuyoshi Matsuoka, Akira Andoh, Yoshio Hirota, Tadakazu Hisamatsu, null null
Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT. Journal of gastroenterology (2023)
Takayuki Yamamoto, Hiroshi Nakase, Kenji Watanabe, Shinichiro Shinzaki, Noritaka Takatsu, Toshimitsu Fujii, Ryuichi Okamoto, Katsuyoshi Matsuoka, Akihiro Yamada, Reiko Kunisaki, Minoru Matsuura, Hisashi Shiga, Shigeki Bamba, Yohei Mikami, Takahiro Shimoyama, Satoshi Motoya, Takehiro Torisu, Taku Kobayashi, Naoki Ohmiya, Masayuki Saruta, Koichiro Matsuda, Takayuki Matsumoto, Atsuo Maemoto, Yoko Murata, Shinichi Yoshigoe, Shinya Nagasaka, Tsutomu Yajima, Tadakazu Hisamatsu, null null
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn's Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn's Disease (iCREST-CD). Journal of Crohn's & colitis (2023)
Fernando Magro, Rish K Pai, Taku Kobayashi, Vipul Jairath, Florian Rieder, Isabel Redondo, Trevor Lissoos, Nathan Morris, Mingyang Shan, Meekyong Park, Laurent Peyrin-Biroulet
Resolving Histologic Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programs. Journal of Crohn's & colitis (2023)
Ferdinando D'Amico, Fernando Magro, Benedicte Caron, Axel U Dignass, Vipul Jairath, Ailsa Hart, Paulo Gustavo Kotze, Kristine Paridaens, Sameer Al Awadhi, Taku Kobayashi, Britta Siegmund, Laurent Peyrin-Biroulet, Silvio Danese
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis. Journal of clinical medicine 12 (3) (2023)
Joel Shor, Yusuke Miyatani, Etsuko Arita, Pohung Chen, Yusuke Ito, Hiroki Kayama, Jacob Reiter, Kaho Kobayashi, Taku Kobayashi
Reducing Health Anxiety in Patients With Inflammatory Bowel Disease Using Video Testimonials: Pilot Assessment of a Video Intervention. JMIR formative research 7 (2023)
Ferdinando D'Amico, Fernando Magro, Benedicte Caron, Axel U Dignass, Vipul Jairath, Ailsa Hart, Paulo Gustavo Kotze, Kristine Paridaens, Sameer Al Awadhi, Taku Kobayashi, Britta Siegmund, Laurent Peyrin-Biroulet, Silvio Danese
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis. Journal of clinical medicine 12 (3) (2023)
Joel Shor, Yusuke Miyatani, Etsuko Arita, Pohung Chen, Yusuke Ito, Hiroki Kayama, Jacob Reiter, Kaho Kobayashi, Taku Kobayashi
Reducing Health Anxiety in Patients With Inflammatory Bowel Disease Using Video Testimonials: Pilot Assessment of a Video Intervention. JMIR formative research 7 (2023)
Yusuke Miyatani, Taku Kobayashi
De-escalation of Therapy in Patients with Quiescent Inflammatory Bowel Disease. Gut and liver (2022)
Shintaro Sagami, Taku Kobayashi, Kanako Aihara, Misaki Umeda, Kazuhiro Odajima, Hiromu Morikubo, Kunio Asonuma, Yusuke Miyatani, Tomohiro Fukuda, Mao Matsubayashi, Hiroki Kiyohara, Masaru Nakano, Toshifumi Hibi
Early improvement in bowel wall thickness on transperineal ultrasonography predicts treatment success in active ulcerative colitis. Alimentary pharmacology & therapeutics 55 (10) (2022)
Shinji Okabayashi, Hajime Yamazaki, Katsuyoshi Matsuoka, Yosuke Yamamoto, Taku Kobayashi
Editorial: is older-onset ulcerative colitis more severe or less aggressively managed? Authors' reply. Alimentary pharmacology & therapeutics 55 (10) (2022)
Shintaro Sagami, Taku Kobayashi
Editorial: the importance of utilising gastrointestinal ultrasound via transperineal approach in ulcerative colitis-an accurate early predictor of response to treatment. Authors' reply. Alimentary pharmacology & therapeutics 55 (9) (2022)
Haruei Ogino, Hiromu Morikubo, Keita Fukaura, Tasuku Okui, Sean Gardiner, Naonobu Sugiyama, Noritoshi Yoshii, Tsutomu Kawaguchi, Haoqian Chen, Edward Nonnenmacher, Soko Setoguchi, Naoki Nakashima, Taku Kobayashi
Validation of a claims-based algorithm to identify cases of ulcerative colitis in Japan. Journal of gastroenterology and hepatology (2021)
Hiromu Morikubo, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Satoshi Kuronuma, Osamu Takeuchi, Tenyo Shiba, Hiroki Kiyohara, Mao Matsubayashi, Shintaro Sagami, Masaru Nakano, Osamu Ikezaki, Tadakazu Hisamatsu, Yoichi Tanaka, Toshifumi Hibi
Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S-methyltransferase inhibition. Journal of gastroenterology and hepatology 36 (8) (2021)
Hiromu Morikubo, Taku Kobayashi, Tomohiro Fukuda, Takayoshi Nagahama, Tadakazu Hisamatsu, Toshifumi Hibi
Development of algorithms for identifying patients with Crohn's disease in the Japanese health insurance claims database. PloS one 16 (10) (2021)
Pablo A Olivera, Stéphane Zuily, Paulo Gustavo Kotze, Veronique Regnault, Sameer Al Awadhi, Peter Bossuyt, Richard B Gearry, Subrata Ghosh, Taku Kobayashi, Patrick Lacolley, Edouard Louis, Fernando Magro, William K K Wu, Alfredo Papa, Timothy Raine, Fabio V Teixeira, David T Rubin, Silvio Danese, Laurent Peyrin Biroulet
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nature reviews. Gastroenterology & hepatology 18 (12) (2021)
Takahiko Toyonaga, Taku Kobayashi, Satoshi Kuronuma, Aito Ueno, Hiroki Kiyohara, Shinji Okabayashi, Osamu Takeuchi, Christopher P F Redfern, Hideki Terai, Ryo Ozaki, Shintaro Sagami, Masaru Nakano, Sally A Coulthard, Yoichi Tanaka, Toshifumi Hibi
Increased DNA-incorporated thiopurine metabolite as a possible mechanism for leukocytopenia through cell apoptosis in inflammatory bowel disease patients with NUDT15 mutation. Journal of gastroenterology 56 (11) (2021)
Shintaro Sagami, Taku Kobayashi, Toshifumi Hibi
Editorial: transperineal ultrasound in addition to a transabdominal ultrasound in ulcerative colitis-one more arrow in the quiver of non-invasive diagnostics. Authors' reply. Alimentary pharmacology & therapeutics 52 (2) (2020)
Shintaro Sagami, Taku Kobayashi, Kanako Aihara, Misaki Umeda, Hiromu Morikubo, Mao Matsubayashi, Hiroki Kiyohara, Masaru Nakano, Makoto Ohbu, Toshifumi Hibi
Transperineal ultrasound predicts endoscopic and histological healing in ulcerative colitis. Alimentary pharmacology & therapeutics 51 (12) (2020)
Mao Matsubayashi, Taku Kobayashi, Shinji Okabayashi, Masaru Nakano, Shintaro Sagami, Ryo Ozaki, Hiroki Kiyohara, Hiromu Morikubo, Kunio Asonuma, Yusuke Miyatani, Shin Maeda, Toshifumi Hibi
Determining the usefulness of Capsule Scoring of Ulcerative Colitis in predicting relapse of inactive ulcerative colitis. Journal of gastroenterology and hepatology 36 (4) (2020)
Taku Kobayashi, Eri Udagawa, Akihito Uda, Toshifumi Hibi, Tadakazu Hisamatsu
Impact of immunomodulator use on treatment persistence in patients with ulcerative colitis: A claims database analysis. Journal of gastroenterology and hepatology 35 (2) (2019)
Shintaro Sagami, Taku Kobayashi, Nao Kikkawa, Satoko Umeda, Masaru Nakano, Takahiko Toyonaga, Shinji Okabayashi, Ryo Ozaki, Toshifumi Hibi
Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease. PloS one 14 (2) (2019)
Takahiko Toyonaga, Taku Kobayashi, Masaru Nakano, Eiko Saito, Satoko Umeda, Shinji Okabayashi, Ryo Ozaki, Toshifumi Hibi
Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome. PloS one 12 (9) (2017)

Taku Kobayashi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Taku Kobayashi